In randomized controlled trials, There's two treatment alternatives at present deemed the common of treatment in Guillain-Barré syndrome (GBS). These consist of possibly intravenous immunoglobulin (IVIG) or plasma exchange. IVIG is thought to act by its immune-modulating action; on the other hand, the exact system remains to be elucidated. IVIG i… Read More